Richardpruen (talk | contribs) (→Perception - safety vs harm - effects on use: add paper comparing medical vs not medical) |
|||
| Line 234: | Line 234: | ||
=Perception - safety vs harm - effects on use= | =Perception - safety vs harm - effects on use= | ||
=== 2023: [https://pubmed.ncbi.nlm.nih.gov/37544328/ Medicalisation of vaping in the UK? E-cigarette users' perspectives on the merging of commercial and medical routes to vaping.] === | |||
* An important paper, investigates the co-existence, synergies and tensions between the two models of vaping for public health - the medicalised and consumer-based approaches - drawing on the insights of users. Great subject, because these two models have entirely different modes of engagement and action. We would ideally like both to work, but it could be problematic if one compromised the impact of the other. | |||
** Three qualitative themes were identified: pro-partnership, anti-partnership and medicalisation dissonance. Medicalisation was discussed for its potential to reassure smokers about e-cigarette harms and its potential to reach smokers from disadvantaged backgrounds. Concerns were raised about cost-effectiveness, quality of support, conflicts of interest and limiting product choice. Most participants rated interventions involving partnership working as potentially helpful in switching from smoking to vaping. There were no statistically significant associations between age, gender and socioeconomic status, and helpfulness ratings. | |||
* Being qualitative, the paper is sprinkled with revealing quotes from vapers... e.g. | |||
** [Millions of] people are now using e-cigarettes in the UK and that this change came about with no involvement of any health professionals whatever. My guess is that the best thing would be for health professionals to leave things as they are, while doing everything they can to counteract adverse media reportage and trumpet the benefits of switching from smoking to e-cigarette use. (Survey participant 21) | |||
* The authors see complementary benefits in pursuing both models... | |||
** Conclusion: Both commercial and medical routes to vaping offer perceived benefits to vapers and may complement and reinforce each other to support smoking cessation. | |||
* Ward E, Dawkins L, Holland R, Pope I, Notley C. Perspect Public Health. 2023 Aug 6:17579139231185481. doi: 10.1177/17579139231185481. Online ahead of print. PMID: 37544328 | |||
=== 2023: [https://pubmed.ncbi.nlm.nih.gov/37182238/ Awareness and beliefs about FDA e-cigarette regulation in the premarket application review era.] === | === 2023: [https://pubmed.ncbi.nlm.nih.gov/37182238/ Awareness and beliefs about FDA e-cigarette regulation in the premarket application review era.] === | ||
* A survey of awareness and attitudes about regulation of e-cigarettes, among adults who smoke and youth (15-20): | * A survey of awareness and attitudes about regulation of e-cigarettes, among adults who smoke and youth (15-20): | ||
* Awareness that FDA regulates e-cigarettes was low among adults who smoke (25.4 %) and youth (18.5 %). Awareness that FDA authorizes e-cigarettes was also low among adults who smoke (10.8 %) and youth (12.7 %). | * Awareness that FDA regulates e-cigarettes was low among adults who smoke (25.4 %) and youth (18.5 %). Awareness that FDA authorizes e-cigarettes was also low among adults who smoke (10.8 %) and youth (12.7 %). | ||
edits